Product Images Otrexup
View Photos of Packaging, Labels & Appearance
- Structure - otrexup 01
- IFU Figure A - otrexup 04
- IFU Figure B - otrexup 05
- IFU Figure C - otrexup 06
- IFU Figure D - otrexup 07
- IFU Figure E - otrexup 08
- IFU Figure F - otrexup 09
- IFU Figure G - otrexup 10
- IFU Figure H - otrexup 11
- 10 mg label - otrexup 13
- 12.5 mg label - otrexup 14
- 15 mg label - otrexup 15
- 17.5 mg label - otrexup 16
- 20 mg label - otrexup 17
- 22.5 mg label - otrexup 18
- 25 mg label - otrexup 19
Product Label Images
The following 16 images provide visual information about the product associated with Otrexup NDC 82497-025 by Otter Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
IFU Figure A - otrexup 04

This is a partial text about the parts of an Otrexup device, including a needle end, warning label, safety clip, and window. The instructions for use are mentioned.*
IFU Figure H - otrexup 11

This text describes a visual indicator system for dosage delivery, with a viewing window that changes when the dosage is administered. The first state is a clear window indicating the absence of a dose, while the second state involves half of the viewing window being blocked by a red flag to signify that a full dose has been delivered. "Figure H" is likely a reference to a diagram or illustration showing this process.*
10 mg label - otrexup 13

Description: This text appears to provide information about a medication called Otrexup (methotrexate), intended for subcutaneous administration once weekly. The text includes recommendations for use and dosage, as well as precautions and possible side effects associated with the medication. For specific details and instructions, it is recommended to consult the original source or a healthcare professional.*
25 mg label - otrexup 19

This is a description for a medication called "Otrexup" meant for subcutaneous injection only. It is to be used once weekly and comes with a kit that includes instructions for use. The text also mentions some warning related to the injection area.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.